Team:UFMG Brazil/modeling
From 2013.igem.org
(Difference between revisions)
Line 61: | Line 61: | ||
The equation that varies with respect to the previous case is: | The equation that varies with respect to the previous case is: | ||
- | [[File:eq9a_tmao.png]] | + | <center>[[File:eq9a_tmao.png]]</center> |
The total concentration of the enzyme is: | The total concentration of the enzyme is: | ||
- | [[File:eq9_tmao.png]] | + | <center>[[File:eq9_tmao.png]]</center> |
Then we considered [[File:eq10_tmao.png]] and imposed [[File:eq11_tmao.png]] and [[File:eq12_tmao.png]] | Then we considered [[File:eq10_tmao.png]] and imposed [[File:eq11_tmao.png]] and [[File:eq12_tmao.png]] | ||
Line 71: | Line 71: | ||
The system of equations also comes from: | The system of equations also comes from: | ||
- | [[File:eq13_tmao.png]] | + | <center>[[File:eq13_tmao.png]]</center> |
Defining [[File:eq14_tmao.png]] and replacing we have: | Defining [[File:eq14_tmao.png]] and replacing we have: | ||
- | [[File:eq15_tmao.png]] | + | <center>[[File:eq15_tmao.png]]</center> |
In conclusion the rate of product appearance results | In conclusion the rate of product appearance results | ||
- | [[File:eq16_tmao.png]] | + | <center>[[File:eq16_tmao.png]]</center> |
- | [[File:tmao_secondModeling.png]] | + | <center>[[File:tmao_secondModeling.png]]</center> |
=Modeling IMA System= | =Modeling IMA System= | ||
Line 89: | Line 89: | ||
The cobalt ion binds to albumin protein, originating the cobalt-albumin complex. If the albumin is derived from a healthy patient, it will bind more cobalt ions than a albumin derived from a patient with heart disease. It happens because patients with heart conditions will have a isquemic modified albumin (IMA), which has less capability of binding to cobalt. Thus, the amount of free cobalt in the system will be determined by the presence of a normal or ischemic albumin in the sample. | The cobalt ion binds to albumin protein, originating the cobalt-albumin complex. If the albumin is derived from a healthy patient, it will bind more cobalt ions than a albumin derived from a patient with heart disease. It happens because patients with heart conditions will have a isquemic modified albumin (IMA), which has less capability of binding to cobalt. Thus, the amount of free cobalt in the system will be determined by the presence of a normal or ischemic albumin in the sample. | ||
- | [[File:eq1_cobalt.png]] | + | <center>[[File:eq1_cobalt.png]]</center> |
==Second Reaction - The entry of cobalt in the cell== | ==Second Reaction - The entry of cobalt in the cell== | ||
Line 95: | Line 95: | ||
There are four cobalt transporters in the cell. The rcnA (Uniprot code: P76425) and zntA (Uniprot code: P37617) transport the cobalt to outside the cell. The corA (Uniprot code: P0ABI4) and zupT (Uniprot code: P0A8H3) transport the cobalt to inside the cell. | There are four cobalt transporters in the cell. The rcnA (Uniprot code: P76425) and zntA (Uniprot code: P37617) transport the cobalt to outside the cell. The corA (Uniprot code: P0ABI4) and zupT (Uniprot code: P0A8H3) transport the cobalt to inside the cell. | ||
- | [[File:eq3_cobalt.png]] | + | <center>[[File:eq3_cobalt.png]]</center> |
The equation for the cobalt flux through these transporters is: | The equation for the cobalt flux through these transporters is: | ||
- | [[File:eq2_cobalt.png]] | + | <center>[[File:eq2_cobalt.png]]</center> |
{{Team:UFMG Brazil/sponsor}} | {{Team:UFMG Brazil/sponsor}} |
Revision as of 04:02, 27 September 2013